How do GPs decide when to refer someone urgently for suspected SCC? 

In the United Kingdom, General Practitioners play a vital role as the first line of detection for skin malignancies. When a patient presents with a concerning skin spot, the doctor must decide whether the lesion can be managed in primary care or if it requires an urgent referral to a specialist dermatology team. This decision is not based on guesswork but on a structured clinical assessment that follows specific evidence-based guidelines. By identifying key physical markers and weighing individual risk factors, a clinician can determine the likelihood of a squamous cell carcinoma and ensure the patient enters the appropriate diagnostic pathway without delay. 

What We’ll Discuss in This Article 

• Clinical red flags including induration and rapid growth 

• How the location of a lesion influences the urgency of a referral 

• The impact of a patient’s immune status on the decision-making process 

• Distinguishing between benign sun damage and invasive cancer 

• The role of dermoscopy in assisting primary care assessments 

• Understanding the two week wait pathway and faster diagnosis standards 

The primary clinical triggers for urgent referral 

The most important physical sign a General Practitioner looks for when assessing a suspected squamous cell carcinoma is induration. This term describes a specific type of firmness or thickening that can be felt within the skin layers. While a benign scaly patch might sit on the surface, an invasive cancer typically feels like a solid, hard lump beneath the crust. NICE clinical guidelines state that a clinician should consider an urgent suspected cancer referral for any skin lesion that raises the suspicion of a squamous cell carcinoma, particularly those showing signs of thickening and ulceration. 

Another major trigger is the speed of evolution. Unlike common warts or slow growing basal cell carcinomas, a squamous cell carcinoma often shows visible expansion over a period of just a few weeks. If a patient reports that a spot has doubled in size or has significantly thickened in the last month, the level of clinical suspicion rises immediately. Pain and tenderness are also significant markers; while many skin cancers are painless, a squamous cell carcinoma is frequently sensitive to pressure, which suggests a higher level of local inflammation and invasion. 

The role of risk factors in the decision process 

A doctor’s decision to refer is also heavily influenced by the patient’s medical history and specific risk profile. In the UK, certain groups are known to have a much higher statistical risk of developing aggressive forms of the disease. For instance, individuals who have had an organ transplant or those who are taking long term immunosuppressant medications are monitored with a much lower threshold for referral. In these patients, a new skin lesion may behave more aggressively and requires a specialist review even if the early signs are subtle. 

The location of the lesion on the body also dictates the level of concern. High risk anatomical sites include the ears, the lips, and the scalp, as well as the backs of the hands. These areas receive the highest cumulative dose of ultraviolet radiation and are places where a cancer can quickly involve deeper structures like cartilage or bone. The National Health Service highlights that squamous cell carcinoma is a type of non melanoma skin cancer that is more common in older people and those with a history of significant sun exposure. If a suspicious, firm lump appears in one of these high-risk zones, a GP is highly likely to initiate an urgent referral. 

Distinguishing cancer from pre-cancerous changes 

One of the most common challenges for a General Practitioner is telling the difference between a pre-cancerous patch, such as actinic keratosis, and an early squamous cell carcinoma. Actinic keratoses are rough, sandpaper like patches that are very common in the UK, especially among fair skinned individuals. While these are often managed with simple creams or freezing in primary care, a doctor must look for signs that the lesion has transformed into a malignancy. 

A key indicator of this transformation is a lack of response to standard treatments. If a scaly patch has been treated with a medicinal cream or cryotherapy but fails to heal or continues to grow, it is a clinical signal that an invasive cancer may be present underneath the surface. GPs often use a dermatoscope, a handheld magnifier with a polarised light source, to look for specific vascular patterns, such as looped or coiled blood vessels, which are characteristic of a squamous cell carcinoma. If these structural markers are seen, or if the lesion is bleeding and crusting repeatedly, an urgent two-week referral is the standard of care. 

The referral process and patient communication 

Once a General Practitioner decides that an urgent referral is necessary, they will explain the process to the patient. In England, this usually involves the two weeks wait pathway, which ensures that the patient is seen by a specialist within fourteen days. The doctor will often take clinical photographs of the lesion to include with the referral. These images allow the hospital’s dermatology triage team to assess the urgency of the case and ensure the patient is seen by the most appropriate specialist, such as a surgeon or a consultant dermatologist. 

The doctor will also provide safety netting advice, explaining exactly what the patient should look for while they wait for their hospital appointment. This includes monitoring for any further rapid growth, new pain, or spontaneous bleeding. By involving the patient in this monitoring process, the GP ensures that any significant changes are noted and communicated to the specialist team. This coordinated approach between primary and secondary care is designed to achieve a definitive diagnosis or rule out cancer as quickly as possible, usually within the twenty-eight-day faster diagnosis standard. 

Conclusion 

General Practitioners decide to refer a patient urgently for a suspected squamous cell carcinoma based on clinical red flags such as induration, rapid growth, and tenderness. They also consider the patient’s immune status and the location of the lesion in high-risk areas like the ears or hands. By following NICE guidelines and using tools like dermoscopy, GPs ensure that suspicious lesions are identified and managed promptly within the NHS specialist system. 

If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot (E-E-A-T) 

This article is designed to provide clear and factual information regarding skin health for the general public. The content is written by the Medical Content Team and has been reviewed by Dr. Stefan Petrov. He is a UK-trained physician with an MBBS and postgraduate certifications including Basic Life Support (BLS), Advanced Cardiac Life Support (ACLS), and the UK Medical Licensing Assessment (PLAB 1 & 2). He has hands-on experience in general medicine, surgery, anaesthesia, ophthalmology, and emergency care. Dr. Petrov has worked in both hospital wards and intensive care units, performing diagnostic and therapeutic procedures, and has contributed to medical education by creating patient-focused health content and teaching clinical skills to junior doctors.